DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Funds either a drug-discovery study or a clinical diagnostic approach for Lyme disease and other tick-borne diseases, aimed at something a clinic could use.
Some tick-borne disease research has already moved past the idea stage and needs to become an actual drug, treatment or diagnostic test. This award funds that next step.
The fiscal year 2026 Tick-Borne Disease Research Program's Therapeutic/Diagnostic Research Award splits into two tracks. Treatment-focused applications are therapeutic evaluation studies aimed at drug or treatment discovery, stil…
Product-driven therapeutic and diagnostic development for Lyme disease and other tick-borne diseases and conditions: therapeutic evaluation studies advancing early or preclinical drug or treatment discovery, or diagnostic approaches designed for integration into clinical settings, funded under the fiscal year 2026 Tick-Borne Disease Research Program.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up